Why I’d buy the Fevertree share price and this FTSE 250 stock right now

G A Chester sees long-term investment appeal in the Fevertree share price (down 75% from its high), and this FTSE 250 stock (down 60%).

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Nick Train — a.k.a. Britain’s Warren Buffett — last year initiated a position in a UK company for the first time in nine years. This was FTSE 250 stock PZ Cussons (LSE: PZC), the owner of personal care and beauty brands.

He’s recently followed this up by swooping for shares in another UK consumer goods firm. Namely, AIM-listed premium mixers maker Fevertree Drinks (LSE: FEVR).

The Fevertree share price has fallen precipitously over the last 18 months. Meanwhile, it’s six-and-a-half years since PZC’s shares were at their peak. Here’s why I’d be happy to buy a stake in both these businesses right now.

Fevertree share price drop

Having peaked at around 4,000p in September 2018, the Fevertree share price is currently trading at 930p. This is a fall of over 75%

I last wrote about the company in summer 2018 when its shares were trading at over 3,400p. The price-to-earnings (P/E) ratio at the time was 87. I concluded: “Much as I admire Fevertree, I rate the stock a ‘sell’ today, due to that eye-watering P/E.” Increasing competition and moderating growth were among the reasons why I felt the P/E was far too fizzy.

Multi-decade growth opportunity

Fevertree is forecast to post earnings per share (EPS) of around 51p when it reports its 2019 results. Following the fall in the share price, the P/E is a far more reasonable 18.2.

Certainly, as with many businesses, the near-term outlook is highly challenging. However, I’m increasingly convinced Fevertree has created, in the words of Nick Train, “a brand of global value and significance.”

Such a brand offers investors the chance to participate in a multi-decade growth opportunity. Neither the upcoming annual report, nor the ongoing impact of Covid-19, changes the long-term story. This — and the discount share price — is why I say I’d be happy to buy a long-term stake in the business right now.

FTSE 250 stock on the rocks

While Fevertree (founded in 2005) is a company in its infancy, PZ Cussons is a long-established consumer goods firm. Its roots go back to 1884 when George Paterson and George Zochonis set up a trading post in Sierra Leone, trading goods between West Africa and the UK.

The business has grown organically and by acquisitions. Notably, PZ acquired Cussons, including leading household soap brand Imperial Leather, in 1975. In the current century, acquisitions have included niche personal care brand Original Source, and leading UK spa brand Sanctuary Spa.

However, growth has been held back in recent years by difficult economic conditions in Nigeria. This is an important market for PZC. As a result, the company’s share price has declined almost 60%, from a high of 425p in late 2013, to 173p today. It trades at a P/E of 13.7 on trailing 12-month EPS of 12.67p.

Return to growth

Notwithstanding the headwinds presented by Nigeria and Covid-19, I believe the company’s long-term future is bright. It’s recently been disposing of peripheral businesses and brands, and focusing investment on its core personal care and beauty brands, such as number one UK anti-bacterial hand wash Carex.

Management reckons the strategy “will enable us to deliver higher margin earnings, in geographies which can scale, and support the return of the group to sustainable, profitable growth.”

For the strength of its brands, and the credibility of its strategy, I rate the stock a long-term ‘buy’ today.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

G A Chester has no position in any of the shares mentioned. The Motley Fool UK owns shares of PZ Cussons. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Could the JD Sports Fashion share price double in the next five years?

The JD Sports Fashion share price has nearly halved in the past five years. Our writer thinks a proven business…

Read more »

Bus waiting in front of the London Stock Exchange on a sunny day.
Investing Articles

If interest rate cuts are coming, I think these UK growth stocks could soar!

Falling interest could be great news for UK growth stocks, especially those that have been under the cosh recently. Paul…

Read more »

Investing Articles

Are these the best stocks to buy on the FTSE right now?

With the UK stock market on the way to hitting new highs, this Fool is considering which are the best…

Read more »

Petrochemical engineer working at night with digital tablet inside oil and gas refinery plant
Investing Articles

Can the Centrica dividend keep on growing?

Christopher Ruane considers some positive factors that might see continued growth in the Centrica dividend -- as well as some…

Read more »

Smiling family of four enjoying breakfast at sunrise while camping
Investing Articles

How I’d turn my £12,000 of savings into passive income of £1,275 a month

This Fool is considering a strategy that he believes can help him achieve a stable passive income stream with a…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

2 top FTSE 250 investment trusts trading at attractive discounts!

This pair of discounted FTSE 250 trusts appear to be on sale right now. Here's why I'd scoop up their…

Read more »

Smiling young man sitting in cafe and checking messages, with his laptop in front of him.
Investing Articles

3 things that could push the Lloyds share price to 60p and beyond

The Lloyds share price has broken through 50p. Next step 60p? And then what? Here are some thoughts on what…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

£1,000 in Rolls-Royce shares a year ago would be worth this much now

Rolls-Royce shares have posted one of the best stock market gains of the past 12 months. But what might the…

Read more »